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Abstract
Infected-cell protein 0 (ICP0) is a RING finger E3 ligase that regulates herpes simplex virus (HSV) mRNA synthesis, and
strongly influences the balance between latency and replication of HSV. For 25 years, the nuclear functions of ICP0 have
been the subject of intense scrutiny. To obtain new clues about ICP0’s mechanism of action, we constructed HSV-1 viruses
that expressed GFP-tagged ICP0. To our surprise, both GFP-tagged and wild-type ICP0 were predominantly observed in the
cytoplasm of HSV-infected cells. Although ICP0 is exclusively nuclear during the immediate-early phase of HSV infection,
further analysis revealed that ICP0 translocated to the cytoplasm during the early phase where it triggered a previously
unrecognized process; ICP0 dismantled the microtubule network of the host cell. A RING finger mutant of ICP0 efficiently
bundled microtubules, but failed to disperse microtubule bundles. Synthesis of ICP0 proved to be necessary and sufficient
to disrupt microtubule networks in HSV-infected and transfected cells. Plant and animal viruses encode many proteins that
reorganize microtubules. However, this is the first report of a viral E3 ligase that regulates microtubule stability. Intriguingly,
several cellular E3 ligases orchestrate microtubule disassembly and reassembly during mitosis. Our results suggest that ICP0
serves a dual role in the HSV life cycle, acting first as a nuclear regulator of viral mRNA synthesis and acting later, in the
cytoplasm, to dismantle the host cell’s microtubule network in preparation for virion synthesis and/or egress.
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Introduction
Herpes simplex virus 1 (HSV-1) is a large, dsDNA virus that is
capable of alternating between two programs of gene expression
that lead to a productive or silent infection. One of HSV’s
immediate-early (IE) proteins, ICP0, is a positive regulator whose
synthesis represents a key step by which HSV ‘‘decides’’ whether
or not an infection is likely to culminate in the production of new
infectious virus (reviewed in Ref. [1]). For example, ICP0 is
sufficient to trigger HSV reactivation in latently infected
trigeminal ganglion neurons [2,3]. At multiplicities of infection
(MOI) above 1 pfu per cell, HSV ICP0-deficient (ICP0
2) viruses
replicate to nearly wild-type levels. In contrast, at MOIs below 0.1
pfu per cell, the same ICP0
2 viruses establish quiescent infections
in 99% of the cells they infect [4,5,6].
ICP0’s mechanism of action is unknown, but the possibilities are
constrained by four facts: 1. ICP0 potentiates ICP4’s function as a
transcriptional activator of HSV mRNA synthesis [7,8,9]; 2. ICP0
is a RING-finger E3 ubiquitin ligase [10,11]; 3. ICP0 is essential
for HSV’s resistance to the innate interferon response of animals
[1,12]; and 4. ICP0’s E3 ubiquitin ligase activity triggers the
dispersal of pro-myelocytic leukemia (PML) nuclear bodies
[13,14], which may contribute to the formation of adjacent, sub-
nuclear replication compartments [15,16].
Point mutations in ICP0’s RING-finger domain (amino acids
116 to 156) destroy ICP0’s E3 ligase activity and destroy ICP0’s
capacity to promote HSV replication [11]. It remains unclear
which substrate(s) explain how ICP0’s E3 ligase activity promotes
HSV replication and spread. Although ICP0 triggers the efficient
dispersal of PML nuclear bodies, ICP0 does not ubiquitinate the
PML protein in an in vitro E3 ligase assay [17].
Like many laboratories, we have been interested in learning how
ICP0 influences outcomes of HSV infection. Our most recent study
clarifies that ICP0 physically interacts with HSV’s major transcrip-
tional regulator, ICP4, and suggests that ICP0 influences whether
ICP4 functionspredominantly asanactivatorora repressorofHSV
mRNA synthesis [9]. However, ICP0’s interaction with ICP4 does
not explain 1. how ICP0 triggers the dispersal of PML nuclear
bodies and centromere proteins [14,18], nor does it explain 2. why
synthesis of ICP0 causes cells to arrest in the G2/M phase of the cell
cycle [19,20]. These latter observations suggest that ICP0 must
interact with at least one cellular protein. Rather than interrogate
specific proteins for their capacity to interact with ICP0, we chose to
use live-cell imaging to determine if new clues might be obtained by
tracking the distribution of a green fluorescent protein (GFP)-tagged
form of ICP0 in HSV-infected cells over time.
Three ICP0
+ viruses were constructed that bore an ,750 bp
insertion of GFP coding sequence inserted in the ICP0 gene. The
resulting recombinant viruses, HSV-1 0
+GFP12, HSV-1 0
+GFP24,
and HSV-1 0
+GFP105 each synthesized a 3.5 kb ICP0
+GFP mRNA
and a 140 kDa protein. Each GFP-tagged ICP0 protein retained
much of ICP0’s activity, and was visible in HSV-1 infected cells by
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e10975fluorescent microscopy. Contrary to our initial expectations, the
majority of GFP-tagged ICP0 was observed in the cytoplasm of
HSV-1 infected cells. Subsequent tests verified that wild-type ICP0
also accumulated to much higher levels in the cytoplasm than in
the nucleus of virus-infected cells.
Since the discovery that ICP0 potently stimulates HSV mRNA
synthesis [7,8], sporadic reports have documented the presence of
ICP0 in the cytoplasm of HSV-infected cells, or have described
ICP0 translocating from the nucleus to the cytoplasm of HSV-
infected cells [21,22,23,24,25]. In recent years, ICP0’s presence in
the cytoplasm of HSV-infected cells has become undeniable, and it
is now well established that ICP0 is incorporated into the
tegument of HSV-1 virions [26,27,28,29]. However, it remains
unclear if ICP0 mediates a specific function in the cytoplasm of
HSV-1 infected cells, or if ICP0 translocates to the cytoplasm for
the sole purpose of its incorporation into HSV-1 virions
[26,27,28,29]. Therefore, most studies of ICP0 continue to focus
on deciphering how this E3 ligase functions in the nucleus to
stimulate HSV mRNA synthesis [9,30,31,32,33,34].
The results of the current study clarify that ICP0 is an exclusively
nuclear protein during the IE phase of HSV infection, but
translocates to the cytoplasm during the early (E) phase. Once in
the cytoplasm of HSV-infected cells, ICP0 efficiently bundles and
disperseshostcellmicrotubules.Microtubulenetworksareknownto
be disrupted in HSV-infected cells [35], but the effectors that
mediate this process are unknown. The HSV-1 tegument protein
VP22 bundles microtubules when overexpressed in transfected cells
[36], but this is not observed in HSV-infected cells [37]. Our results
demonstrate that ICP0 is necessary and sufficient to trigger the
complete disassembly of the host cell microtubule network. This
finding adds to a growing list of proteins encoded by plant and
animal viruses that reorganize microtubules [38,39,40,41].
This is the first report of a viral E3 ligase that regulates
microtubule stability. Intriguingly, cellular E3 ligases such as the
anaphase-promoting complex and cullin 3 orchestrate massive
reorganizations of microtubules during mitosis [42,43,44]. ICP0-
like E3 ligases are not unique to herpes simplex virus, but are
encoded by at least 20 other a-herpesviruses that infect primates,
pigs, dogs, kangaroos, and other species [45,46]. The results of the
current study suggest that these a-herpesvirus-encoded E3 ligases
fulfill a dual function of 1. immediately stimulating viral gene
expression in the nucleus, and 2. acting later, in the cytoplasm, to
dismantle the host cell’s microtubule network in preparation for
virion synthesis and/or egress.
Results
Characterization of HSV viruses that express GFP-tagged
ICP0
Three ICP0
+GFP genes were constructed that encoded GFP-
tagged ICP0 in which i. GFP replaced amino acids 1 to 11 of the
775-amino acid ICP0 protein (ICP0
+GFP-12); ii. GFP was inserted
between amino acids 23 and 24 of ICP0 (ICP0
+GFP-24); or iii. GFP
was inserted between amino acids 104 and 105 of ICP0
(ICP0
+GFP-105) (Fig. 1A). An ICP0-null control gene, the ICP0
2GFP
gene, encoded only the N-terminal 104 amino acids of ICP0 fused
to GFP (Fig. 1A). Chimeric ICP0
GFP genes were introduced into
the LAT-ICP0 locus of HSV-1 strain KOS by homologous
recombination to yield HSV-1 0
2GFP, 0
+GFP12,0
+GFP24,o r
0
+GFP105 (Fig. 1B). Northern blot analysis verified that each of
these viruses synthesized the predicted 3.5 kb ICP0
GFP mRNA
(Fig. 1C). GFP-tagged ICP0 proteins were analyzed by two-color
Western blot analysis. In cells infected with wild-type HSV-1 KOS
or KOS-GFP, ICP0-specific monoclonal antibody H1083 labeled
the 110 kDa ICP0 protein (red band in Fig. 1D). In addition, the
GFP-expressing recombinant virus, KOS-GFP [47], also encoded
an ,30 kDa GFP protein that was labeled by rabbit anti-GFP
antibody (green band in Fig. 1D). HSV-1 0
2GFP encoded a
truncated ,55 kDa protein that was only labeled by the GFP-
specific antibody, whereas the 0
+GFP viruses encoded ,140 kDa
ICP0
+GFP-12, -24, and -105 proteins that were labeled with both
ICP0- and GFP-specific antibodies (yellow bands in Fig. 1D).
The functionality of ICP0
+GFP-12, -24, and -105 proteins was
compared to ICP0. Wild-type HSV-1 formed plaques with 100%
efficiency in Vero cells relative to the number of plaques that
formed in ICP0-complementing L7 cells (Fig. 1E). In contrast,
only ,1% of HSV-1 0
2GFP (ICP0
2) viruses formed plaques in
Vero cells (Fig. 1E). Each HSV-1 0
+GFP virus formed plaques in
Vero cells at ,66% efficiency relative to the number of plaques
that formed in ICP0-complementing L7 cells (Fig. 1E). Thus,
ICP0
+GFP-12, -24, or -105 protein each retained sufficient activity to
promote HSV-1 plaque formation with 45-fold greater efficiency
than the ICP0
2 null control virus, HSV-1 0
2GFP.
GFP-tagged ICP0 is predominantly observed in the
cytoplasm of HSV-infected cells
In cells transfected with the plasmids p0
+GFP12,p 0
+GFP24,o r
p0
+GFP105, the ICP0
+GFP-12, -24, or -105proteins each accumulated in
the nuclei of transfected cells in a punctate pattern, typical of wild-
type ICP0 (Fig.2A–C; [13,14]). Incontrast,the truncated ICP0
2GFP
protein was distributed in a nuclear and perinuclear pattern in cells
transfected with the plasmid p0
2GFP (Fig. 2D). When expressed
in the context of HSV-1 infection, ICP0
+GFP-12, -24, or -105
protein was predominantly observed in the cytoplasm of virus-
infected cells. For example, ICP0
+GFP-12 was predominantly
observed in the cytoplasm of cells at the outer edge of plaques
formed by HSV-1 0
+GFP12 (white arrow in Fig. 2E). Likewise, the
ICP0
+GFP-24 and ICP0
+GFP-105 proteins were primarily detected in
the cytoplasm of cells at the outer edge of plaques formed by HSV-1
0
+GFP24andHSV-10
+GFP105,respectively(whitearrowsinFig.2F,
2G).Incontrast, theICP0
2GFP peptide expressed by HSV-10
2GFP
accumulated throughout virus-infected cells (Fig. 2H).
The subcellular distribution of ICP0
+GFP-24 protein was
monitored in Vero cells inoculated with 10 pfu per cell of HSV-
10
+GFP24. At 3 hours p.i., GFP-tagged ICP0 was evident in the
nuclei of many cells infected with HSV-1 0
+GFP24 (Fig. 3A).
However, ICP0
+GFP-24 only accumulated to high levels after
5 hours p.i., at which time the protein had translocated to the
cytoplasm of most HSV-1 0
+GFP24-infected cells (Fig. 3A). To
determine if the translocation of ICP0
+GFP-24 was replication-
dependent, an HSV-1 ICP4
2 null virus was constructed, HSV-1
0
+GFP24-D4. In cells inoculated with HSV-1 0
+GFP24-D4, the
nuclear-to-cytoplasmic translocation of ICP0
+GFP-24 occurred with
kinetics similar to the ICP4
+ virus (Fig. 3B). ICP0
+GFP-24 was
observed in bright perinuclear lines and globular bodies when
overexpressed from the ICP4
2 null virus (Fig. 3B). Intriguingly,
this pattern of cytoplasmic ICP0 was equivalent to the findings of
Knipe and Smith (1986) [21], who first described ICP0’s
cytoplasmic distribution in cells inoculated with an HSV-1 ICP4
mutant. Live-cell imaging of HSV-1 0
+GFP24-D4-infected cells
demonstrated that the cytoplasmic bodies in which ICP0
+GFP-24
protein accumulated were highly mobile (Video S1). In addition,
cytoplasmic ICP0
+GFP-24 was often observed in linear arrays that
encircled the nucleus (denoted by asterisks in Fig. 3B).
These observations raised questions both about the requirements
for ICP0’s nuclear-to-cytoplasmic translocation, and what function
ICP0 might fulfill in the cytoplasm of HSV-1 infected cells. Further
experiments were performed to address these questions.
ICP0 Dismantles Microtubules
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e10975Figure 1. Characterization of HSV-1 viruses that express GFP-tagged ICP0. (A) Schematic of the wild-type or chimeric ICP0 genes in
wild-type HSV-1 strain KOS or the recombinant viruses, HSV-1 0
+GFP12,0
+GFP24, and 0
+GFP105,a n d0
2GFP. (B) Southern blot analysis of the ICP0
locus of HSV-1 KOS versus HSV-1 recombinant viruses based on hybridization of an ICP0 intron1-specific probe to DNA digested with StuI and
HpaI (ICP0 gene), StuI and BamHI (exon 1 fragment), or PshAI and BssHII (exon 2 fragment). (C) Northern blot analysis with an ICP0-v e r s u sGFP-
specific probes hybridized to 10 mg total RNA isolated from Vero cells that were uninfected (no virus) or were infected with the specified HSV-1
viruses (MOI=10; RNA harvested 12 hours p.i.). (D) Two-color Western blot analysis of cells that were uninfected (no virus) or were infected
with the specified HSV-1 viruses (MOI=10; protein harvested 18 hours p.i.). (E) Efficiency of plaque formation by HSV-1 KOS, 0
-GFP, 0
+GFP12,
0
+GFP24,o r0
+GFP105 in Vero cells relative to the number of plaques that formed in ICP0-complementing L7 cells (mean 6 sem; n=3 cultures
per group).
doi:10.1371/journal.pone.0010975.g001
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PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e10975Figure 2. GFP-tagged ICP0 is predominantly cytoplasmic in HSV-1 infected cells. (A) ICP0
+GFP-12,( B )I C P 0
+GFP-24, (C) ICP0
+GFP-105,o r( D )I C P 0
2GFP
asseeninVerocells12 hoursposttransfectionwiththeplasmidsp0
+GFP12,p0
+GFP24,p 0
+GFP105,o rp 0
2GFP,respectively.Eachplasmidwasco-transfected
with the plasmid pBHad.CMV-VP16 to induce the ICP0 promoter and expression of GFP-tagged ICP0. (E) ICP0
+GFP-12, (F) ICP0
+GFP-24,( G )I C P 0
+GFP-105,o r( H )
ICP0
2GFP as seen in Vero cells 40 hours post inoculation with the HSV-1 recombinant viruses 0
+GFP12,0
+GFP24,0
+GFP105,o r0
2GFP, respectively. In each
panel, an entire plaque is shown on the right, and one edge of the plaque is magnified on the left. White arrows denote HSV-1 infected cells in which GFP-
tagged ICP0 was abundant in the cytoplasm, but was not evident in the nuclei of HSV-1 infected cells. The scale bar denotes a distance of 10 mm.
doi:10.1371/journal.pone.0010975.g002
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HSV-1 replication cycle
Although HSV-1 ICP4
2 null viruses overexpress viral IE
proteins, a considerable leak of E proteins such as the large
subunit of HSV’s ribonucleotide reductase (ICP6) occurs in the
absence of ICP4 [48,49]. To determine if HSV-1 IE proteins were
indeed sufficient to promote GFP-tagged ICP0’s translocation to
the cytoplasm, chemical inhibitors were used to unambiguously
separate HSV-1 protein synthesis into its IE and E phases. Vero
cells were treated with cycloheximide to block protein translation,
and cells were inoculated with 5 pfu per cell of HSV-1 0
+GFP105.
After allowing 6 hours for the accumulation of viral IE mRNAs,
cycloheximide was removed and cultures were released into
medium containing either the mRNA synthesis inhibitor actino-
mycin D [50], the DNA synthesis inhibitor acyclovir [51] or no
inhibitor (vehicle).
In HSV-1 0
+GFP105-infected cells released into medium
containing actinomycin D, ICP0
+GFP-105 remained in the
nuclei of .90% of cells at 1 and 4 hours post-release
from a cycloheximide block (Fig. 4A). Thus, translocation of
ICP0
+GFP-105 failed to occur when only viral IE proteins were
efficiently expressed. When HSV-1 0
+GFP105-infected cells were
released into medium containing acyclovir (IE and E proteins
expressed), ICP0
+GFP-105 was initially observed in nuclei, but
translocated to the cytoplasm of most cells by 4 hours post-release
(Fig.4A).Likewise,whencycloheximidetreatmentwasfollowed with
vehicle, ICP0
+GFP-105 translocated to the cytoplasm with similar
kinetics (Fig. 4A). Parallel tests with HSV-1 0
+GFP12,0
+GFP24,a n d
0
+GFP24-D4 yielded equivalent results (not shown). These results
suggested that the nuclear-to-cytoplasmic translocation of ICP0
+GFP-
105 occurred during the E phase of HSV-1 replication.
To determine if these results were relevant to wild-type ICP0,
similar tests were performed with wild-type HSV-1 strain KOS
[52]. When cycloheximide treatment was followed with actino-
mycin D, wild-type ICP0 was retained in the nuclei of KOS-
infected cells at 4 hours post-release (Fig. 4B). In contrast, when
cycloheximide treatment was followed with acyclovir or vehicle,
wild-type ICP0 translocated to the cytoplasm by 4 hours post-
release and was observed in globular and linear structures that
encircled the nuclei of .90% of KOS-infected cells (Fig. 4B).
Therefore, both GFP-tagged ICP0 and wild-type ICP0 were
predominantly nuclear during the IE phase of viral infection, but
rapidly translocated to the cytoplasm when viral E protein
synthesis was allowed to occur.
ICP0
+GFP-105 disperses linear structures in the cytoplasm
of HSV-1 infected cells
The cytoplasmic structures in which ICP0 accumulated did not
appear to be mitochondria, lysosomes, Golgi apparatus, or
endoplasmic reticulum based upon the failure of ICP0 to co-
localize with MitoTracker dye [53], LysoTracker dye [54], Golgi
marker b-COP [55], or the endoplasmic reticulum marker
calreticulin [56]. Moreover, in early attempts to isolate the
fluorescent-ICP0 labeled cytoplasmic bodies by density gradient
sedimentation, it was noted that the bodies rapidly dispersed upon
homogenization of cells in ice-cold buffer (not shown). To gather
further clues about the nature of these structures, live-cell imaging
Figure 3. ICP0
+GFP-24 translocates to the cytoplasm of HSV-1
infected cells in the presence or absence of ICP4. ICP0
+GFP-24
protein in Vero cells inoculated with 10 pfu per cell of HSV-1 0
+GFP24
(left column) or HSV-1 0
+GFP24-D4 (right column) between 3 and
8 hours p.i. White asterisks denote cells in which ICP0
+GFP-24 was
observed in a linear pattern encircling the nucleus of HSV-1 infected
cells. The scale bar denotes a distance of 10 mm.
doi:10.1371/journal.pone.0010975.g003
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+GFP-105
in the cytoplasm of HSV-1 0
+GFP105-infected cells.
Cycloheximide was used to alleviate ICP4-dependent repression
of the ICP0
GFP gene, such that ICP0
+GFP-105 mRNA could
accumulate to high levels and be synchronously translated upon
cycloheximide release [9]. At 1 hour post-release, ICP0
+GFP-105 was
observed exclusively in the nuclei of HSV-1 0
+GFP105-infected cells
(Table 1, Fig. S1A). Between 2 and 4 hours post-release, ICP0
+GFP-105
had partially or completely translocated to the cytoplasm of .90% of
HSV-1 0
+GFP105-infected cells (Table 1, Fig. S1A). At 4 hours post-
release, ICP0
+GFP-105 was observed in linear cytoplasmic structures in
1661% of 0
+GFP105-infected cells (Table 1, Fig. S1A). However, by
6 hours post-release, ICP0
+GFP-105 was rarely observed in linear
cytoplasmic structures (Table 1, Fig. S1A).
We considered the possibility that ICP0
+GFP-105 might trigger
the dispersal of cytoplasmic structures in much the same manner
that ICP0 triggers the dispersal of PML nuclear bodies [13,14]. To
test this hypothesis, a recombinant virus was constructed, HSV-1
0DRING, which encoded a GFP-tagged ICP0
DRING protein that
was deleted of amino acids 105–221, and thus lacked ICP0’s
RING-finger domain [10]. When cycloheximide-release experi-
ments were performed in cells inoculated with HSV-1 0DRING,
the ICP0
DRING protein accumulated in linear cytoplasmic
structures between 2 and 6 hours post-release (Table 1, Fig.
S1B). Intriguingly, ICP0
DRING was rarely observed in globular
bodies, but rather the protein was observed almost exclusively in
linear cytoplasmic structures (Table 1, Fig. S1B). These findings
suggested that ICP0
DRING stably accumulated in linear cytoplas-
mic structures, whereas ICP0
+GFP-105 triggered the dispersal of
these structures upon accumulating at these sites.
To test this hypothesis, live-cell imaging was used to track the
fate of linear structures in which ICP0
+GFP-105 accumulated. Cells
Figure 4. ICP0 translocates to the cytoplasm during the early phase of HSV-1 replication. (A) ICP0
+GFP-105 protein in Vero cells inoculated
with HSV-1 0
+GFP105 following release from a cycloheximide block. Cultures were inoculated with 5 pfu per cell of HSV-1 0
+GFP105, treated with
200 mM cycloheximide from 20.5 to 6 hours p.i., and released into medium containing actinomycin D (10 mg/ml), 300 mM acyclovir, or vehicle (no
inhibitor). Cultures were photographed at 7 and 10 hours p.i. (B) ICP0 in HSV-1 KOS-infected Vero cells following release from a cycloheximide block.
Cultures were inoculated with 5 pfu per cell of KOS, treated with cycloheximide from 20.5 to 6 hours p.i., released into medium containing
actinomycin D, acyclovir, or vehicle, and fixed for immunofluorescent staining at 7 and 10 hours p.i. White asterisks denote cells in which ICP0 was
observed in a linear pattern encircling the nucleus of HSV-1 infected cells. The scale bar denotes a distance of 10 mm.
doi:10.1371/journal.pone.0010975.g004
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+GFP105 and time-lapse photogra-
phy was conducted between 4.0 and 4.5 hours post-release from a
cycloheximide block. Linear, cytoplasmic arrays of ICP0
+GFP-105
that initially encircled the nucleus were found to be unstable, and
dispersed into smaller, globular bodies over a 10- to 20-minute
time frame (Fig. 5A, Video S2). In contrast, experiments with
HSV-1 0DRING demonstrated that the ICP0
DRING protein stably
accumulated in linear cytoplasmic structures which grew visibly in
length and thickness between 4.0 and 4.5 hours post-release
(Fig. 5B, Video S3). This trend continued until 6 hours post-
release, at which time the experiment was terminated (not shown).
Therefore, ICP0
+GFP-105 translocated to the cytoplasm, accumu-
lated in linear cytoplasmic structures, and then triggered the
dispersal of these structures in a RING-finger-dependent manner.
ICP0 co-localizes with disrupted microtubule networks in
HSV-1 infected cells
The linear cytoplasmic structures in which ICP0
+GFP-105
transiently accumulated were reminiscent of microtubule bundles
formed by HSV-1’s VP22 protein [36]. Therefore, we considered
the possibility that ICP0
+GFP-105 and ICP0
DRING proteins might
associate with host cell microtubules. To test this hypothesis,
cycloheximide-release experiments were performed in cells
inoculated with HSV-1 0DRING, HSV-1 0
+GFP105, or wild-type
HSV-1 KOS. At 4 hours post-release, cells were fixed and
immunofluorescently stained for a-tubulin and ICP0. In uninfect-
ed Vero cells, a-tubulin staining revealed a normal network of
microtubules that radiated from the microtubule-organizing center
at the periphery of the nucleus (Fig. 6). In cells inoculated with
HSV-1 0DRING, a-tubulin staining revealed extensive thickening
of microtubules into elongated bundles that circumscribed the
nucleus, and co-localized with the ICP0
DRING protein (Fig. 6). In
cells inoculated with HSV-1 0
+GFP105, a-tubulin staining revealed
that the microtubule network had dispersed into small a-tubulin
+,
globular bodies that co-localized with ICP0
+GFP-105 (Fig. 6). In
cells inoculated with wild-type HSV-1 KOS, the host cell
microtubule network was also disrupted, and a-tubulin was
dispersed into a-tubulin
+ globular bodies that co-localized with
ICP0 (Fig. 6). Although the ICP0
DRING protein bundled
microtubules, it failed to trigger their dispersal into globular
bodies (Fig. 6). These results raised the possibility that HSV’s E3
ligase, ICP0, might contribute to microtubule disassembly in
HSV-infected cells [35]. Further experiments were conducted to
test the validity of this hypothesis.
ICP0
DRING protein accumulates in linear structures that
are nocodazole-sensitive
If microtubules did indeed provide the underlying scaffold on
which ICP0
DRING protein accumulated in linear arrays (Fig. 5, 6),
then inhibition of microtubule polymerization with nocodazole
[57] should recapitulate the effect of ICP0’s RING finger domain.
Specifically, nocodazole treatment, like wild-type ICP0, should
Table 1. Subcellular distribution of ICP0
GFP in HSV-1 infected cells at times after release from a cycloheximide block
a.
Virus Hours Subcellular distribution
b Cytoplasmic pattern
e
ICP0
GFP only in nucleus ICP0
GFP in cytoplasm ICP0
GFP in lines ICP0
GFP in globules
HSV-1 0
+GFP105 11 0 0 60
c 060
d 060
f 060
g
29 619 1 612 609 8 60
32 609 8 601 0 619 0 61
42 609 8 601 6 617 7 61
52 609 8 601 1 618 1 61
61 609 9 601 608 7 61
HSV-1 0DRING 1 100600 600 600 60
24 0 626 0 629 6 604 60
33 9 616 1 619 7 603 60
43 4 616 6 619 9 601 60
52 6 617 4 619 9 601 60
62 2 617 8 619 9 601 60
aVero cells were inoculated with 5 pfu per cell of HSV-1 0
+GFP105 or HSV-1 0DRING in the presence of 200 mM cycloheximide from 20.5 to 10 hours p.i., and were
released into medium containing no drugs. Cultures were photographed between 1 and 6 hours post-release to record the position of all nuclei (visualized with
Hoechst 33342) and the subcellular localization of ICP0
+GFP-105 or ICP0
DRING. Representative photographs that formed the basis for the data presented above are shown
in Fig. S1.
bFrequency of cells in which ICP0
+GFP-105 or ICP0
DRING was observed exclusively in the nucleus (left column) versus cells in which proteins were observed in either the
cytoplasm and nucleus or just in the cytoplasm (right column).
cFrequency of cells (mean 6 sem) in which ICP0
+GFP-105 or ICP0
DRING was observed exclusively in the nucleus. The frequency reported at each time point was calculated
as 1006number of cells in which ICP0
GFP was observed solely in the nucleus4number of ICP0
GFP+ cells. Each value is based on n=4 independent cultures, and each
estimate of frequency was based on n=400 Hoechst
+ cells. Between 4 and 6 hours post-release, 9561% of cells in HSV-1 inoculated cultures were positive for the
ICP0
+GFP-105 or ICP0
DRING proteins.
dFrequency of cells (mean 6 sem) in which ICP0
+GFP-105 or ICP0
DRING was observed in the cytoplasm and nucleus, or just in the cytoplasm. Frequencies were calculated
by the method described in footnote c.
eFrequency of ICP0
+GFP-105 or ICP0
DRING accumulating in linear arrays (left column) versus globular patterns (right column) in the cytoplasm of HSV-1 infected cells.
fFrequency of cells (mean 6 sem) in which ICP0
+GFP-105 or ICP0
DRING were observed in linear cytoplasmic arrays that encircled Hoechst
+ nuclei. The presence of one or
more linear arrays of ICP0
GFP was the basis for scoring a cell as having ‘‘ICP0
GFP in lines.’’ The frequency reported at each time point was calculated as 1006number of
cells containing linear arrays of ICP0
GFP protein4number of cells in which ICP0
GFP was evident in the cytoplasm. Each value is based on n=4 independent cultures, and
each estimate of frequency was based on n=400 Hoechst
+ cells.
gFrequency of cells (mean 6 sem) in which ICP0
+GFP-105 or ICP0
DRING were observed in globular, cytoplasmic bodies, which was calculated as described in footnote f.
doi:10.1371/journal.pone.0010975.t001
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ICP0
DRING protein to disperse into smaller bodies. To test this
prediction, cells were infected with HSV-1 0DRING in the
presence of cycloheximide for 10 hours, and were released into
medium containing no inhibitor. Four hours later, the stability of
linear arrays of ICP0
DRING protein was compared in the presence
or absence of nocodazole.
In the absence of nocodazole, ICP0
DRING protein stably
accumulated in linear structures that encircled the nucleus of
HSV-1 0DRING-infected cells between 4.0 and 4.5 hours post-
release (Fig. 7A, Video S3). In contrast, nocodazole treatment
caused linear accumulations of ICP0
DRING protein to disperse into
small globular bodies within 10 to 30 minutes, and the time
required for dispersal varied in proportion to the thickness of each
bundle (Fig. 7B, Video S4). Nocodazole-induced, ICP0
DRING+
globular bodies were identical in appearance to a-tubulin
+
globular bodies that co-localized with ICP0 and ICP0
+GFP-105
(Fig. 6). Independent tests verified that nocodazole-induced,
ICP0
DRING+ globular bodies were also a-tubulin
+ (not shown).
These observations indicated that the linear cytoplasmic
structures in which ICP0
DRING protein accumulated were indeed
microtubule bundles. This finding was also consistent with our
prior observation that ICP0
+GFP-105-containing bodies rapidly
dispersed upon homogenization in ice-cold buffer; a condition
known to cause depolymerization of microtubules [58].
ICP0 is necessary for efficient dispersal of microtubules in
HSV-1 infected cells
It is well established that the host cell microtubule network is
disrupted during the course of HSV-1 infection [35,59,60].
However, it is unclear what process triggers microtubule
reorganization in HSV-1 infected cells. We questioned whether
this event might be ICP0-dependent. To test this hypothesis, a-
tubulin and ICP0 staining were compared in Vero cells that were
uninfected (UI) or were inoculated with HSV-1 KOS, HSV-1
0
+GFP105,o ra nICP0
2 null virus, HSV-1 0
2GFP. Cells were
inoculated with 5 pfu per cell of each virus in the presence of
cycloheximide for 10 hours to allow high and equivalent levels of
ICP0
+ and ICP0
2 mRNAs to accumulate [9]. At 1 and 4 hours
post-release, a normal distribution of a-tubulin staining was noted
in uninfected Vero cells; specifically, microtubules radiated from
the microtubule-organizing center on one side of the nucleus
(Fig. 8A). At 1 hour post-release, ICP0 and ICP0
+GFP-105 were obser-
ved in the nuclei of cells infected with HSV-1 KOS and 0
+GFP105
(Fig. 8A). Importantly, a-tubulin staining was always normal when
ICP0 or ICP0
+GFP-105 were confined to the nucleus (Fig. 8A).
However, at 4 hours post-release, ICP0 and ICP0
+GFP-105 had
translocated to the cytoplasm and this event coincided with
dispersal of microtubules in KOS- and 0
+GFP105-infected cells,
respectively (Fig. 8B). Specifically, microtubule-organizing centers
were no longer discernible, and a-tubulin was dispersed into
globular bodies that co-localized with ICP0 or ICP0
+GFP-105
(Fig. 8B). In contrast, at 1 and 4 hours post-release, cells inoculated
with HSV-1 0
2GFP retained an intact microtubule network that
radiated from a perinuclear microtubule-organizing center
(Fig. 8A, 8B). Likewise, at 6 and 8 hours post-release, microtubule
networks remained intact in HSV-1 0
2GFP-infected cells (Fig. S2).
Therefore, synthesis of ICP0 appeared to be necessary for the
efficient dismantling of microtubule networks that normally occurs
in HSV-1 infected cells [35].
ICP0 is sufficient to dismantle microtubule networks in
transfected cells
The HSV-1 proteins US11 [61], UL34 [62], VP26 [63] and
VP22 [36] interact with host cell microtubules. Thus, ICP0 might
be one of many HSV proteins that is required to disperse the
intracellular ‘freeway system’ that is the cell’s microtubule network
[64]. Alternatively, synthesis of ICP0 alone might be sufficient to
disperse cellular microtubules. To differentiate between these
possibilities, Vero cells were transfected with pICP0, p0
+GFP105,
or p0DRING to determine if synthesis of ICP0 proteins affected
the subcellular distribution of a-tubulin, one of the principal
structural subunits of the hollow, polymeric tubes known as
microtubules [65].
A normal distribution of a-tubulin staining was noted in mock-
transfected Vero cells at 12 and 24 hours post-transfection.
Specifically, microtubules radiated from the organizing center on
Figure 5. ICP0
+GFP-105 disperses linear cytoplasmic structures in
a RING-finger-dependent manner. Vero cells were inoculated with
5 pfu per cell of (A) HSV-1 0
+GFP105 or (B) HSV-1 0DRING in the presence
of 200 mM cycloheximide from 20.5 to 10 hours p.i., and were released
into medium containing no drugs. Between 4.0 and 4.5 hours post-
release, time-lapse photographs were collected of the ICP0
+GFP-105 or
ICP0
DRING proteins that encircled the nucleus of HSV-1 infected cells.
The scale bar denotes a distance of 10 mm.
doi:10.1371/journal.pone.0010975.g005
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nuclei of mock-transfected Vero cells (Fig. 9A, 9B). Consistent with
prior results (Fig. 2A–2C), wild-type ICP0 and ICP0
+GFP-105 were
observed in the nuclei of cells transfected with pICP0 and p0
+GFP105
at 12 hours post-transfection (Fig. 9A). At this early time, a normal
distribution of a-tubulin staining was noted in the cytoplasm, but to
our surprise significant amounts of a-tubulin were present in the
nuclei and co-localized with wild-type ICP0 and ICP0
+GFP-105
Figure6.ICP0co-localizeswithreorganizedmicrotubulesinHSV-1infectedcells.Immunofluorescent stainingofVero cells that were uninfected
(no virus) or that were inoculated with 5 pfu per cell of HSV-1 0DRING, HSV-1 0
+GFP105,orwild-type HSV-1 strain KOS.Cells were inoculated in the presence
of 200 mM cycloheximide from 20.5 to 10 hours p.i., and were released into medium containing no drugs. At 4 hours post-release, uninfected cells and
KOS-infected cells were fixed and stained with antibodies against a-tubulin (rabbit IgG, Alexa Fluor 594) and ICP0 (mouse IgG, fluorescein). Nuclei were
counterstainedwiththeDNA-bindingdyeHoechst33342.HSV-10DRING and 0
+GFP105- i n fe ct e dc e l l swe r efi x e da nds ta i n e dfora-tubulin,andtheICP0
DRING
and ICP0
+GFP-105 proteins were visualized using their GFP fluorophores. The scale bar denotes a distance of 10 mm.
doi:10.1371/journal.pone.0010975.g006
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that the appearance of co-localization was not an unintended
consequence of bleedover between the red and green channels (not
shown). In cells transfected with p0DRING, the ICP0
DRING protein
was also observed in the nuclei of cells at 12 hours post-transfection,
and a normal distribution of a-tubulin staining was noted in the
cytoplasm. However, large amounts of a-tubulin were present in the
nuclei of transfected cells, and a-tubulin co-localized with the
ICP0
DRING p r o t e i n( F i g .9 A ,F i g .S 3 ) .
At 24 hours post-transfection, wild-type ICP0 and ICP0
+GFP-105
were observed in the nuclei and cytoplasm of cells transfected with
pICP0 and p0
+GFP105, respectively (Fig. 9B). Translocation of
ICP0 or ICP0
+GFP-105 to the cytoplasm consistently correlated
with 1. dissolution of the host cell microtubule-organizing center
and microtubule network, and 2. co-localization of a-tubulin with
ICP0 or ICP0
+GFP-105 in small, globular bodies in the cytoplasm
(Fig. 9B; Fig. S3). Likewise, 24 hours after transfection with
p0DRING, ICP0
DRING protein co-localized with a-tubulin in
elongated microtubule bundles (Fig. 9; Fig. S3). Therefore,
synthesis of the ICP0
DRING protein was sufficient to trigger
bundling, but not dispersal of microtubules. In contrast, wild-type
ICP0 was sufficient to trigger a complete dispersal of host cell
microtubules.
ICP0 translocation and microtubule dispersal in a single
HSV-1 plaque
High MOIs and cycloheximide-release experiments allowed
robust visualization of ICP0 and co-localization of ICP0 with
dispersed a-tubulin. These tests left unaddressed the question of
whether or not ICP0 actually translocates and/or dismantles
microtubule networks during the normal progression of HSV-1
infection. To address this issue, Vero cells were inoculated with
wild-type virus at an MOI of 0.0001 pfu per cell, and the
distribution of ICP0 and a-tubulin was analyzed in isolated HSV-1
plaques at 40 hours p.i. A single, representative plaque is
considered to illustrate our findings (Fig. 10, Fig. S4).
With the enhanced sensitivity of immunofluorescent staining (versus
direct imaging of GFP fluorescence, Fig. 2), low levels of ICP0 were
detectable in the nuclei of cells at the outermost, advancing edge of
HSV-1 plaques (N symbols, Fig. 10A, Fig. S4A). In those HSV-1
infected cells in which ICP0 was observed solely in the nucleus,
the perinuclear pattern of microtubule staining remained normal
(N symbols, Fig. 10B, Fig. S4B). Behind this advancing front, a second
row of HSV-1 infected cells was observed in which ICP0 was far more
abundant and predominantly localized to the cytoplasm of HSV-1
infected cells (X symbols, Fig. 10A, Fig. S4A). When ICP0
accumulated in the cytoplasm of HSV-1 infected cells, gross
reorganization of the cellular microtubule network was observed (X
symbols, Fig. 10B, Fig. S4B). Moreover, a-tubulin was frequently
observed reorganized into linear structures or globular bodies that co-
localized with wild-type ICP0 (white arrows, Fig. 10, Fig. S4).
Therefore, we conclude that regardless of MOI, a nuclear-to-
cytoplasmic translocation of ICP0 routinely occurs in HSV-1 infected
cells, and the timing of ICP0’s translocation to the cytoplasm coincides
with a massive reorganization of the host cell’s microtubule network.
Discussion
ICP0 serves distinct roles in the nucleus and cytoplasm of
HSV-infected cells
Studies of ICP0 have focused on the protein’s role in the nucleus
[18,30,31,32]. Cytoplasmic ICP0 has been repeatedly observed
[21,22,23,24,25], but its significance remains obscure for two
reasons. First, the kinetics of ICP0’s nuclear-to-cytoplasmic
translocation has been poorly defined. Thus, it has not been
apparent that ICP0’s function in the cytoplasm is kinetically
delayed and is only manifest once ICP0 fulfills its IE function in
the nucleus [7,8,9]. Second, the role that ICP0 fulfills in the
cytoplasm of HSV-infected cells has not been clearly articulated.
The results of the current study address these gaps in knowledge.
The results of the current study demonstrate that once E
proteins accumulate, ICP0 translocates to the cytoplasm (Fig. 4)
and there dismantles the host cell’s microtubule network. Five
observations support this conclusion: 1. Microtubule dispersal is
ICP0-dependent in HSV-infected cells (Fig. 8); 2. Synthesis of
ICP0 is sufficient to trigger microtubule dispersal (Fig. 9); 3.
Dispersal of microtubule bundles is dependent upon ICP0’s RING
Figure 7. ICP0
DRING accumulates in linear structures that are
nocodazole-sensitive. Vero cells were inoculated with 5 pfu per cell of
HSV-1 0DRING in the presence of 200 mM cycloheximide from 20.5 to
10 hours p.i., and were released into medium containing no drugs. At
4 hours post-release, a representative field of view was chosen, and cells
weretreatedwith(A)vehicleor(B)10 mg/mlnocodazole.Between4.0and
4.5 hours after cycloheximide release, time-lapse photographs were
captured at 10-minute intervals. White asterisks denote cells in which
ICP0
DRING was observed in a continuous, linear pattern encircling the
nucleus ofHSV-1infectedcells.Thescalebar denotesadistanceof10 mm.
doi:10.1371/journal.pone.0010975.g007
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coincides with ICP0’s translocation to the cytoplasm (Fig. 8); and
5. dispersed a-tubulin co-localizes with ICP0 (Fig. S3).
GFP-tagged ICP0 yields new insights into the biology of
ICP0
HSV-1 viruses that encoded chimeric ICP0
+GFP proteins formed
plaques with ,66% efficiency relative to wild-type HSV-1 (Fig. 1E).
Using this new tool, we were able to observe GFP-tagged ICP0 in the
act of bundling and/or dispersing microtubules in the cytoplasm of
HSV-infected cells (Videos S2, S3). These findings would be difficult
to ascertain from analysis of fixed cells because ICP0’s cytoplasmic
pattern is pleomorphic in HSV-infected cells. However, direct
observation of a single HSV-infected cell in real time revealed the
fluid process by which GFP-tagged ICP0 triggered the disassembly of
subcellular structures that proved to be bundled microtubules (Figs. 5
and 6; Table 1; Video S2).
Virus-induced reorganization of host cell microtubules
Many animal and plant viruses use host cell microtubule
networks during their replication cycle [39,40,41]. For example,
movement protein of tobacco mosaic virus [66] and transmission
Figure 8. ICP0 is necessary for dispersal of microtubule networks in HSV-1 infected cells. Vero cells were uninfected or were inoculated
with 5 pfu per cell of HSV-1 strain KOS, HSV-1 0
+GFP105, or HSV-1 0
2GFP in the presence of 200 mM cycloheximide from 20.5 to 10 hours p.i., and
were released into medium containing no drugs until the time of fixation. At (A) 1 hour post-release or (B) 4 hours post-release, uninfected and KOS-
infected cells were fixed and stained with antibodies against a-tubulin (rabbit IgG) and ICP0 (mAb H1083). HSV-1 0
+GFP105 or 0
2GFP-infected cells
were fixed and stained for a-tubulin, and ICP0
+GFP-105 and ICP0
2GFP proteins were visualized using their GFP fluorophores. Nuclei were counterstained
with the DNA-binding dye Hoechst 33342. The scale bar denotes a distance of 10 mm.
doi:10.1371/journal.pone.0010975.g008
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plant cells. The human immunodeficiency virus Rev protein forms
dimers that bind microtubule ends, and inhibit their polymeriza-
tion [68]. The 3C protease of foot-and-mouth disease virus cleaves
microtubule-associated protein 4, and thus excludes microtubules
from cytoplasmic replication compartments [38,69]. Expression of
Epstein-Barr virus’s LMP-1 protein or SV40’s large T antigen
causes formation of aberrant microtubule structures via the
respective modulation of microtubule-stabilizing proteins RASSF1
A [70] and TACC2 [39]. While many viruses modify the
microtubule network during their replication cycles, the functional
significance of these interactions is often unclear. Thus, there is no
clear virological precedent that explains why HSV should encode
a protein, ICP0, that dismantles the microtubule network.
ICP0: a viral E3 ligase that orchestrates microtubule
disassembly
The current study provides the first example of a viral E3 ligase
that triggers microtubule disassembly. The genomes of at least 16
a-herpesviruses encode RING-finger E3 ligases, and these proteins
constitute a family of ICP0-like proteins that are functional
Figure 9. ICP0 is sufficient to trigger dispersal of host cell microtubule networks. Vero cells were mock-transfected or were transfected
with a VP16-expressing plasmid and pICP0, p0
+GFP105, or p0DRING. At (A) 12 hours post-transfection or (B) 24 hours post-transfection, mock- and
pICP0-transfected cells were fixed and stained with antibodies against a-tubulin (rabbit IgG) and ICP0 (mAb H1083). Cells transfected with p0
+GFP105
or p0DRING were fixed and stained to visualize a-tubulin, and the ICP0
DRING and ICP0
+GFP-105 proteins were visualized using their GFP fluorophores.
The scale bar denotes a distance of 10 mm.
doi:10.1371/journal.pone.0010975.g009
ICP0 Dismantles Microtubules
PLoS ONE | www.plosone.org 12 June 2010 | Volume 5 | Issue 6 | e10975homologs of one another [45]. Therefore, it is reasonable to expect
that the ICP0-like proteins of all a-herpesviruses should likewise
fulfill dual roles in the nucleus and cytoplasm of virus-infected cells
[9], and thus should trigger disassembly of microtubule networks
upon their translocation to the cytoplasm. Further testing will be
required to validate this prediction.
The a-herpesviruses are not alone in their use of E3 ligases as
regulatory molecules. The Rta protein of Kaposi’s sarcoma
herpesvirus possesses intrinsic E3 ligase activity despite the absence
of a canonical RING finger domain [71]. Smaller RNA and DNA
viruses exploit ubiquitination as a regulatory mechanism by
encoding adapter proteins such as adenovirus E1b, papillomavirus
E6 and E7, or paramyxovirus V proteins that redirect cellular E3
ligases to substrates that benefit the virus [71,72,73,74,75]. It will
be of interest to determine in coming years if any of these other
viral E3 ligases reorganize host cell microtubule networks.
Many cellular E3 ligases play a prominent role in coordinating
the complex events that transpire during mitosis, and which
include disassembly of the microtubule network [43]. For example,
cullin 3 is an E3 ligase that regulates the activity of a microtubule-
Figure 10. Translocation of ICP0 and disruption of host cell microtubules in a single HSV plaque. Vero cells were inoculated with wild-
type HSV-1 KOS virus at an MOI of 0.0001 pfu per cell, and cells were fixed and stained at 40 hours p.i. using antibodies against (A) ICP0 and (B) a-
tubulin. Nuclei were counterstained with the DNA-binding dye Hoechst 33342. Cells in which ICP0 was observed solely in the nucleus are denoted by
a circle (N) to the right of the nucleus. Cells in which ICP0 was prominent in the cytoplasm are denoted with an ‘X’ to the right of the nucleus. White
arrows denote cells in which a-tubulin was not only dispersed, but also co-localized with ICP0. The scale bar denotes a distance of 10 mm.
doi:10.1371/journal.pone.0010975.g010
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[43,44,76]). Given the propensity of viruses to steal useful cellular
functions [71,77], our results raise the possibility that ICP0 may be
functionally homologous to cellular E3 ligases that influence cell-
cycle progression by regulating the stability of microtubule
networks [43]. Further investigation will be required to explore
this important hypothesis.
Is a-tubulin a substrate of ICP0’s E3 ligase activity?
The discovery of ICP0’s E3 ligase activity by Everett and
colleagues [10,78] arose from a need to explain why PML nuclear
bodies were dispersed shortly after ICP0 arrived in these sub-
nuclear structures [13,14,15]. Although it seemed likely that PML
would prove to be a direct substrate of ICP0’s E3 ligase activity,
the development of a robust in vitro assay for ICP0’s E3 ligase
activity demonstrated that this was not the case [10,17].
It is possible that a-tubulin may be a direct substrate of ICP0’s
E3 ligase activity, but the history of ICP0 research suggests that
such speculation is premature. What should be considered,
however, is the extraordinarily robust co-localization of a-tubulin
and ICP0. For example, in transfected cells, large amounts of a-
tubulin co-localized with ICP0 in the nucleus, which is not normally
observed in uninfected cells (Fig. 9, Fig. S3). These results suggest
that newly synthesized ICP0 may be tethered to a-tubulin so
rapidly in the cytoplasm that the ICP0-containing complexes that
are imported into the nucleus may also contain sizable amounts of
a-tubulin. Moreover, ICP0 co-localized with dispersed a-tubulin
+
structures for hours after disassembly of the microtubule network
(Fig. 6, 8, 9). In contrast, ICP0’s nuclear interactions with PML
[13,15] and ICP4 [9,79] appear to be far more transient in nature.
Clearly, further work is needed to define how ICP0’s E3 ligase
activity triggers microtubule disassembly in host cells, and to
define why ICP0’s co-localization with a-tubulin appears to be so
much more stable than any other cellular protein identified to
date.
ICP0-induced disassembly of microtubules versus G2/M
cell cycle arrest
Synthesis of ICP0 causes dividing cells to arrest in the G2/M
phase of the cell cycle [18,19,20]. Two explanations for this
phenomenon have been offered including ICP0-induced degra-
dation of centromere protein-C [18], and ICP0-induced activation
of a DNA damage response pathway [80]. The current study
suggests a third possibility; ICP0-induced disassembly of microtu-
bules produces the same type of G2/M arrest that is caused by
nocodazole [81]. Like, nocodazole, ICP0 triggers the rapid
disassembly of microtubule networks in cells. Nocodazole causes
cells to arrest in the G2/M phase of the cell cycle by blocking
mitotic spindle formation, which is needed to align chromosomes
on the metaphase plate prior to their segregation into daughter
cells [81]. Likewise, synthesis of ICP0 has nocodazole-like effects
on cell division [19,20]. Specifically, chromosome condensation
occurs normally in cells treated with ICP0-expressing viruses [18]
or nocodazole [82], but in both cases the condensed chromosomes
fail to align on metaphase plates [18,82]. Further work will be
required to test the validity of this interpretation, and determine if
ICP0-induced disassembly of microtubules explains why synthesis
of ICP0 causes cell division to stall during mitosis.
Conclusion
In recent years, the list of viruses that interact with cellular
microtubules has grown in length, but the general significance of
the phenomenon remains unclear. Herpesviruses rely on micro-
tubules as a ‘conveyor belt’ to carry their incoming virions from
the cell membrane to the nuclear pore [64,83]. Therefore, it is
conceivable that disruption of this conveyor belt may be critical for
virion egress, such that newly formed herpesvirus virions may flow
efficiently in the reverse direction, from the nucleus back to the cell
membrane. Clearly, further studies will be required to determine
precisely why ICP0 translocates to the cytoplasm and destabilizes
the host cell microtubule network during the E phase of HSV
infection.
Materials and Methods
Cells, viruses, and plasmids
Vero cells, ICP0-complementing L7 cells [84], and ICP4-
complementing E5 cells [85] were propagated in Dulbecco’s
Modified Eagle’s medium (DMEM) containing 0.15% HCO3
2
supplemented with 5% fetal bovine serum (FBS), penicillin G
(100 U/ml), and streptomycin (100 mg/ml), hereafter referred to
as ‘‘complete DMEM.’’ ICP4-complementing E5 and ICP0-
complementing L7 cell lines were kindly provided by Neal Deluca
(University of Pittsburgh; [84,85]). HSV-1 strain KOS was used as
the parent wild-type virus in this study. KOS and all of the HSV-1
recombinant viruses used in this study were propagated in Vero
cells, L7 cells, or E5 cells cultured in complete DMEM. KOS-GFP
is a recombinant virus derived from HSV-1 strain KOS that
expresses GFP from a CMV promoter cassette inserted in the
intergenic region at the 39 ends of the UL26 and UL27 genes
[47,86]. To construct HSV-1 recombinant viruses, a 7.3 kb DNA
fragment which encompasses the entire LAT-ICP0 locus was first
subcloned from HSV-1 strain KOS into a pCRII plasmid vector
(Invitrogen Corporation, Carlsbad, CA). Mutations were intro-
duced into the ICP0 gene of this plasmid, as described below.
i. p0+GFP12. A GFP coding sequence was amplified from
plasmid peGFP-N1 (Clontech Laboratories, Mountain View, CA)
using PCR primers that added NcoI and Bsu36I restriction sites to
the 59 and 39 ends of the GFP coding sequence. Following PCR
amplification with a high fidelity mixture of thermostable DNA
polymerases, the GFP sequence was subcloned into NcoI and
Bsu36I sites that occur in codons 1 and 11 of the ICP0 coding
sequence. The resulting plasmid, p0
+GFP12, encoded ICP0
+GFP-12
protein. The genetic identity of this and all GFP insertions in the
ICP0 gene was confirmed by DNA sequencing. Homologous
recombination between HSV-1 KOS and the p0
+GFP12 plasmid
yielded the recombinant virus HSV-1 0
+GFP12.
ii. p0+GFP24. The plasmid p0
+GFP24 was created by PCR
amplification of three DNA fragments that were ligated in series to
create a GFP insertion at the 59 end of exon 2 of the ICP0 gene
(Fig. 1A). Specifically, 1. the 39 end of intron 1 of the ICP0 gene;
2. a GFP coding sequence; and 3. the 59 half of exon 2 of the ICP0
gene were PCR-amplified, ligated together, sequenced, and the
resulting BamHI - XhoI fragment was subcloned into the BamHI -
XhoI sites in the ICP0 gene. The resulting plasmid, p0
+GFP24,
encoded ICP0
+GFP-24 protein in which GFP is inserted between
amino acids 23 and 24 of ICP0. Homologous recombination
between HSV-1 KOS and the p0
+GFP24 plasmid yielded the
recombinant virus HSV-1 0
+GFP24.
iii. p0-GFP. The plasmid p0
2GFP gene was created by
inserting a polylinker, GFP coding sequence, and stop codon
derived from the plasmid peGFP-N1 (Clontech Laboratories) into
a XhoI site in codon 104 of the ICP0 gene. The resulting plasmid,
p0
2GFP, encoded the N-terminal 104 amino acids of ICP0, a 14
amino acid linker, and GFP. Homologous recombination between
HSV-1 KOS and the p0
2GFP plasmid yielded the recombinant
virus HSV-1 0
2GFP.
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+GFP105 was derived by
subcloning a dsDNA linker containing BsrGI and XhoI sites
(tgtaca agatat ctcgag) in the 39 end of the GFP coding sequence in
p0
2GFP. Thus, a TAA terminator codon was removed and the
GFP and ICP0 coding sequences were placed in the same open-
reading frame. The resulting plasmid, p0
+GFP105, encoded
ICP0
+GFP-105 protein in which GFP is inserted between amino
acids 104 and 105 of ICP0. Homologous recombination between
HSV-1 KOS and p0
+GFP105 yielded the virus HSV-1 0
+GFP105.
v. p0DRING. The plasmid p0DRING was derived by
deletion of codons 105–229 of the ICP0 gene from p0
+GFP105.
Homologous recombination between HSV-1 KOS and the
p0DRING plasmid yielded the recombinant virus HSV-1
0DRING.
Construction of recombinant HSV-1 viruses
Infectious HSV-1 DNA was prepared by a protocol that relies
upon dialysis to minimize shearing of genome-length HSV-1
DNA; this is a modification of a protocol that was generously
provided by Karen Mossman (McMaster University, Hamilton,
Ontario). Five 100 mm dishes of Vero cells (3610
7 cells) were
inoculated with 5 pfu per cell of HSV-1 strain KOS. After
24 hours, cells were scraped, centrifuged, rinsed with PBS,
resuspended in 7.0 ml of 200 mM EDTA pH 8.0, and transferred
into a 15 ml conical. Proteinase K (75 ml of 10 mg/ml) and 375 ml
of 10% SDS were added to virus-infected cells, and the tube was
incubated in a rotisserie oven with slow rotation at 50uC for
16 hours. Proteins were removed by phenol : chloroform
extraction, and DNA was transferred into a 0.5–3.0 mL Slide-a-
lyzer cassette (10,000 MW cutoff; Pierce Chemical Co., Rockford,
IL) and dialyzed against 0.16standard saline citrate for 24 hours.
Following dialysis, infectious HSV-1 DNA was aliquoted and
frozen at 280uC.
Recombinant HSV-1 viruses were generated by co-transfection
of 2 mg infectious HSV-1 KOS DNA and 1 mg each plasmid into a
60 mm dish containing 8610
5 ICP0-complementing L7 cells.
After 12 hours, medium was replaced with complete DMEM
containing 1% methylcellulose and GFP
+ plaques were selected on
a Nikon TE2000 fluorescent microscope (Nikon Instruments,
Lewisville, TX). GFP
+ recombinant viruses were repeatedly passed
in ICP0-complementing L7 cells until a uniform population of
viruses was obtained that produced 100% GFP
+ plaques, at which
time Southern blot analysis was used to confirm that the
anticipated mutation had been introduced into the ICP0 gene of
HSV-1.
Southern blot analysis
Vero cell cultures were established at a density of 1.5610
6 cells
per 100 mm dish and were inoculated with viruses at an MOI of 5
pfu per cell. DNA was harvested from virus-infected cells or
uninfected controls at 24 hours p.i. using a standard DNA
extraction procedure and Southern blot analysis was performed
as previously described [87,88]. Oligonucleotide probes specific
for intron 1 of the ICP0 gene (59-cccctagatgcgtgtgag-
taaggggggcctgcgtatgagt-39) were used to probe restriction frag-
ments of HSV-1 viruses.
Northern blot analysis of ICP0
GFP mRNA
Vero cell cultures were established at a density of 1.5610
6 cells
per plate in 60 mm dishes. Vero cells were inoculated with viruses
at an MOI of 10 pfu per cell. RNA was isolated from each
treatment group at 12 hours p.i. using Ultraspec RNA isolation
reagent (Biotecx Inc., Houston, TX), and Northern blot analysis
was performed as previously described [2,9]. The oligonucleotide
probes used were specific for either exon 3 of ICP0 mRNA (59-
ggagtcgctgatcactatggggtctctgttgtttgcaagg-39) or the GFP coding
sequence (59-atagacgttgtggctgttgtagttgtactcc-agcttgtgc-39) [9,89].
Western blot analysis of ICP0
GFP reporter proteins
Vero cell cultures were established at a density of 3610
5 cells
per well in 12-well plates, and were infected at an MOI of 10 pfu
per cell. After 18 hours, proteins were harvested using mammalian
protein extraction reagent (Pierce Chemical Co., Rockford, IL)
supplemented with 1 mM dithiothreitol and protease inhibitor
cocktail set I (Calbiochem, La Jolla, CA). After heat denaturation,
20 mg of each protein sample and MagicMark
TM XP protein MW
markers (Invitrogen Corporation, Carlsbad, CA) were resolved in
a 10% polyacrylamide gel with a 4% stacking gel, and were
transferred to nitrocellulose membranes. Protein blots were
blocked in phosphate-buffered saline (PBS) containing 5% nonfat
dry milk, and were incubated overnight at 4uC in PBS+0.1%
Tween-20+5% nonfat dry milk containing a 1:1000 dilution of
mouse monoclonal H1083 antibody specific for amino acids 395
to 775 of ICP0 [79,90,91] (EastCoast Bio, North Berwick, MA)
and a 1:500 dilution of rabbit polyclonal anti-GFP antibody
(Clontech Laboratories Inc.). Following incubation with primary
antibodies, membranes were washed four times with PBS+0.1%
Tween-20 (PBS-T), and were incubated for 1 hour with 1:20,000
dilution of goat anti-rabbit IgG and goat anti-mouse IgG
conjugated, respectively, to the infrared fluorescent dyes IRDyeH
680 and IRDyeH 800CW (LI-COR Bioscience, Lincoln, NE).
Protein blots were washed three times in PBS-T, and were scanned
for two-color fluorescence using the Odyssey Infrared imaging
system (LI-COR Bioscience). Data were analyzed using Odyssey
application software version 3.0.16 (LI-COR Bioscience).
Immunofluorescent staining in Vero cells
Immunofluorescent staining in Vero cells was performed using
an adaptation of a staining protocol that was generously provided
by Roger Everett (MRC Virology Unit, Glasgow, Scotland). Glass
coverslips were placed on the bottom of 6-well dishes and Vero
cells were seeded at a density of 1610
6 cells per well. After
allowing 8 hours for cell attachment, cultures were inoculated with
HSV-1 viruses using the conditions defined in each Figure Legend
and Results sub-section. At the indicated time of harvest, glass
coverslips were removed from culture wells with fine forceps, and
were fixed with PBS containing 1.9% formaldehyde and 2%
sucrose for 10 minutes, followed by permeabilization with 90%
methanol for 10 minutes. HSV-1 Fc-c receptors (glycoprotein E-I
heterodimers [92]) were blocked along with all other non-specific
protein-binding sites by incubating fixed cells in a solution of PBS
containing 0.5% fetal bovine serum (FBS), as well as 10 mg/ml
each of the c-globulin fractions of human, donkey, and goat serum
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).
Fixed cells were incubated in PBS+FBS+c-globulin block solution
for 10 minutes, and the same solution was used as the diluent for
primary and secondary antibodies. Each protein of interest was
labeled by incubating fixed cells in a 1:1000 dilution of primary
antibody for 16 hours. Excess primary antibody was removed by
washing with PBS+FBS+c-globulin block solution, and cells were
then incubated for 1 hour in PBS+FBS+c-globulin block contain-
ing a 1:1000 dilution of each secondary antibody as well as 10 ng/
ml of Hoechst 33342 to apply a blue label to the nuclei of cells
(Calbiochem, La Jolla, CA). Excess secondary antibody was
removed by washing with the PBS+FBS+c-globulin block solution,
and coverslips were mounted on glass slides using FluorSave
Reagent (Calbiochem, Gibbstown, NJ). Cells on coverslips were
photographed using an Olympus BX41 microscope equipped with
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PA). Images of green, red, and blue fluorescence were captured at
exposure times of 500, 200, and 20 ms, respectively.
The primary antibodies were mouse a-ICP0 monoclonal
antibody H1083 (EastCoast Bio), rabbit anti-a-tubulin polyclonal
antibody ab18251 (Abcam, Cambridge, MA), rabbit anti-b-COP
polyclonal antibody ab2899 (Abcam, Cambridge, MA), rabbit
anti-calreticulin polyclonal antibody ab4 (Abcam, Cambridge,
MA). The secondary antibodies were Alexa Fluor 594-conjugated
goat a-mouse IgG (Molecular Probes, Eugene, OR), fluorescein-
conjugated goat a-mouse IgG (Jackson ImmunoResearch), or
DyLight 594-conjugated donkey a-rabbit IgG (Jackson Immu-
noResearch).
Live-cell imaging and video analysis of GFP-tagged ICP0
in HSV-1 infected cells
Live-cell imaging was performed by placing a Nikon TE2000
microscope in a 37uC warm room and culturing Vero cells in
HEPES-buffered (pH 7.9) RPMI medium containing 5% fetal
bovine serum (Gibco BRL, Gaithersburg MD). Time-lapse
photography was made possible by outfitting the microscope with
an Olympus DP72 digital camera (Olympus America, Center
Valley, PA) and a computer containing Olympus DP2-BSW
microscope digital camera software which controlled the operation
of a Lambda SC SmartShutter
TM control system (Sutter
Instrument, Novato, CA). Images were captured at 30-second
intervals to create Videos S1, S2, S3, S4, or were captured at 10-
minute intervals to create static Figures 5 and 7. Time-lapse videos
were set to play at a rate of 5 frames per second (2.5 minutes per
second of video), such that the motion of GFP-tagged ICP0 shown
in videos occurs 150 times faster than real time.
Transfection of Vero cells
Vero cells were transfected with plasmid DNA (0.75mg/well in
12-well plates) using Lipofectamine 2000 (Invitrogen Corporation,
Carlsbad, CA) in complete DMEM at 37uC. Medium was
replaced at 4 hours post-transfection to avoid toxicity associated
with the transfection reagent, and cells were incubated at 37uCi n
complete DMEM until cells were fixed for immunofluorescent
staining.
Supporting Information
Figure S1 ICP0
+GFP-105 disperses linear cytoplasmic structures
in HSV-1 0
+GFP105-infected cells. Vero cells were inoculated with
5 pfu per cell of (A) HSV-1 0
+GFP105 or (B) HSV-1 0DRING in
the presence of 200 mM cycloheximide from 20.5 to 10 hours p.i.,
and were released into medium containing no drugs. Photographs
of (A) ICP0
+GFP-105 or (B) ICP0
DRING between 1 and 6 hours after
release from the cycloheximide block. The scale bar denotes a
distance of 10 mm.
Found at: doi:10.1371/journal.pone.0010975.s001 (6.55 MB TIF)
Figure S2 Microtubule networks remain intact in cells infected
with an ICP0
2 null virus, HSV-1 0
2GFP. Vero cells were
uninfected or were inoculated with 5 pfu per cell of inoculated
with HSV-1 0
2GFP in the presence of 200 mM cycloheximide
from 20.5 to 10 hours p.i., and were released into medium
containing no drugs. At 4, 6, or 8 hours post-release, cells were
fixed and stained with rabbit antibody against a-tubulin and the
truncated ICP0
2GFP peptide was directly visualized. The scale bar
denotes a distance of 10 mm.
Found at: doi:10.1371/journal.pone.0010975.s002 (5.81 MB
TIF)
Figure S3 Co-localization of ICP0 and a-tubulin in cells
transfected with ICP0-expressing plasmids. Merged images of
the a-tubulin and ICP0 staining shown in Figure 9 in cells that
were mock transfected, or which were transfected with pICP0,
p0
+GFP105,o rp 0 DRING. The scale bar denotes a distance of
10 mm.
Found at: doi:10.1371/journal.pone.0010975.s003 (7.18 MB TIF)
Figure S4 Enlarged image of one portion of an HSV-1 plaque in
which ICP0 translocation, a-tubulin dispersal, and co-localization
of ICP0 and a-tubulin are observed. Enlarged photographs of (A)
ICP0-staining and (B) a-tubulin staining from Figure 10.
Found at: doi:10.1371/journal.pone.0010975.s004 (7.30 MB TIF)
Video S1 Rapid movement of ICP0
+GFP-24-labeled globular
bodies in HSV-1 0
+GFP24-D4-infected cells. Time-lapse photo-
graphs of ICP0
+GFP-24 protein in a representative field of Vero
cells between 6.0 and 6.5 hours after inoculation with 5 pfu per
cell of HSV-1 0
+GFP24-D4. Cultures were continuously incubated
at 37uC before and during time-lapse photography. Photographs
were captured at a rate of twice per minute for 30 minutes, and
are shown in this video at an elapsed rate that is 150 times faster
than normal.
Found at: doi:10.1371/journal.pone.0010975.s005 (6.26 MB
MOV)
Video S2 ICP0
+GFP-105 disperses linear cytoplasmic structures in
HSV-1 0
+GFP105-infected cells. Time-lapse photographs of
ICP0
+GFP-105 protein in a representative field of Vero cells
between 4.0 and 4.5 hours post-release from a cycloheximide
block. Vero cells were inoculated with 5 pfu per cell of HSV-1
0
+GFP105 in the presence of 200 mM cycloheximide from 20.5 to
10 hours p.i., and were released into medium containing no drugs.
At 4.0 hours post-release, a field of cells was chosen where
ICP0
+GFP-105 was present in linear cytoplasmic structures.
Cultures were continuously incubated at 37uC before and during
time-lapse photography. Photographs were captured at a rate of
twice per minute for 30 minutes, and are shown in this video at an
elapsed rate that is 150 times faster than normal.
Found at: doi:10.1371/journal.pone.0010975.s006 (7.70 MB
MOV)
Video S3 ICP0
DRING accumulates in linear cytoplasmic struc-
tures in HSV-1 0DRING-infected cells. Time-lapse photographs
of ICP0
DRING protein in a representative field of Vero cells
between 4.0 and 4.5 hours post-release from a cycloheximide
block. Vero cells were inoculated with 5 pfu per cell of HSV-1
0DRING in the presence of 200 mM cycloheximide from 20.5 to
10 hours p.i., and were released into medium containing no drugs.
At 4.0 hours post-release, a field of cells was chosen where
ICP0
DRING was present in linear cytoplasmic structures. Cultures
were continuously incubated at 37uC before and during time-lapse
photography. Photographs were captured at a rate of twice per
minute for 30 minutes, and are shown in this video at an elapsed
rate that is 150 times faster than normal.
Found at: doi:10.1371/journal.pone.0010975.s007 (9.37 MB
MOV)
Video S4 Bundles of ICP0
DRING disperse following nocodazole
treatment of HSV-1 0DRING-infected cells. Vero cells were
inoculated with 5 pfu per cell of HSV-1 0DRING in the presence
of 200 mM cycloheximide from 20.5 to 10 hours p.i., and were
released into medium containing no drugs. At 4.0 hours post-
release, a field of cells was chosen and a 36solution of nocodazole
was added to culture medium to achieve a final concentration of
10 mg/ml. Time-lapse photography of ICP0
DRING protein was
commenced 1 minute later. Cultures were continuously incubated
ICP0 Dismantles Microtubules
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were captured at a rate of twice per minute for 30 minutes, and
are shown in this video at an elapsed rate that is 150 times faster
than normal.
Found at: doi:10.1371/journal.pone.0010975.s008 (5.42 MB
MOV)
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